exhibit 10. 1 settlement and termination of license agreement besins healthcare luxembourg sarl and its affiliates ( “ besins ” ) and atossa genetics, inc. ( “ atossa ” ) ( collectively with besins, the “ parties ” ) enter into this settlement and termination of license agreement ( “ termination agreement ” ) as of this 4th day of august, 2016 ( the “ effective date ” ). recitals a. besins and atossa entered into an intellectual property license agreement as of may 14, 2015 ( “ license agreement ” ) which provided, among other terms, that besins granted to atossa an exclusive, transferable license under besins core ip and besins platform ip to make, have made, manufacture, have manufactured, use, sell, have sold, offer to sell, have offered to sell, import, have imported, export, have exported, and otherwise transfer, dispose of, distribute, or develop and improve afimoxifene gel for the sole purposes of atossa obtaining regulatory approval and commercialization of afimoxifene gel in the field in the territory during the term and practicing any method claimed in the besins core ip and besins platform ip in the field in the territory during the term. b. prior to entering into the license agreement, in connection with its due diligence efforts, and subsequent to entering into the license agreement, atossa received from and / or was provided access to substantial amounts of besins ’ proprietary and confidential information. c. after entering into the license agreement, besins and atossa disputed certain terms and conditions of the license agreement, including the scope of the rights granted to atossa pursuant to the license agreement. d. when besins and atossa could not resolve the dispute through negotiations, atossa filed suit on january 29, 2016, against besins in the united states district court for the district of delaware ( “ court ” ) in a case captioned atossa genetics, inc. v. besins healthcare luxembourg sarl, case no. 1 : 16 - cv - 00045 ( gms ) ( the “ litigation ” ), claiming, among other allegations, that besins had breached the license agreement. atossa sought damages and declaratory relief. besins answered the complaint on march 8, 2016, denying the atossa allegations and asserting counterclaims against atossa alleging that atossa breached